Watson
Executive Summary
Investment banking firm CIBC World Markets is retained to assist in the evaluation of possible alternatives, including possible divestiture, for its two sterile injectable manufacturing facilities in Phoenix, Ariz. and Cherry Hill, N.J. Watson acquired the facilities through its recent acquisition of Schein, completed Aug. 28 (1"The Pink Sheet" May 29, p. 27). Watson said it will continue to market the injectable products INFeD and Ferrlecit. Although INFeD is manufactured at the Phoenix facility, Watson will consider a contract manufacturing arrangement for the product. Watson also names former Schein Senior VP-Quality Donald Britt as Senior VP-corporate quality assurance